A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients
| Authors： | Lu, F., Q. Zhou, L. Liu, G. D. Zeng, W. M. Ci, W. T. Liu, G. Zhang, Z. Y. Zhang, P. Wang, A. Q. Zhang, Y. F. Gao, L. Yu, Q. Y. He and L. Chen |
|---|---|
| PubYear： | 2020 |
| Journal： | Theranostics |
